Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help?

Schneider, Marc P.; Tellenbach, Marc; Mordasini, Livio; Thalmann, George N.; Kessler, Thomas M. (2013). Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU international, 112(2), E159-E163. Blackwell Science 10.1111/bju.12005

Text Schneider_BJU Int_2013_112_E159.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (162kB)

Objective

To evaluate the effect of transcutaneous electrical nerve stimulation (TENS) for treating men with refractory chronic pelvic pain syndrome (CPPS).

Patients and Methods

A consecutive series of 60 men treated with TENS for refractory CPPS was evaluated prospectively at an academic tertiary referral centre.
The effects of treatment were evaluated by a pain diary and by the quality of life item of the National Institutes of Health Chronic Prostatitis Symptom Index at baseline, after 12 weeks of TENS treatment, and at last known follow-up.
Adverse events related to TENS were also assessed.

Results

The mean (95% confidence interval, CI; range) age of the 60 men was 46.9 (43.5–50.3; 21–82) years.
TENS was successful after 12 weeks of treatment in 29 (48%) patients and a positive effect was sustained during a mean (95%, CI; range) follow-up of 43.6 (33.2–56; 6–88) months in 21 patients. After 12 weeks of TENS treatment, mean (95% CI) pain visual analogue scale decreased significantly (P < 0.001) from 6.6 (6.3–6.9) to 3.9 (3.2–4.6).
Patients' quality of life changed significantly after TENS treatment (P < 0.001). Before TENS, all 60 patients felt mostly dissatisfied (n = 17; 28%), unhappy (n = 28; 47%) or terrible (n = 15; 25%). After 12 weeks of TENS treatment, 29 (48%) patients felt mostly satisfied (n = 5), pleased (n = 18) or delighted (n = 6).
No adverse events related to TENS were noted.

Conclusion

TENS may be an effective and safe treatment for refractory CPPS in men, warranting randomized, placebo-controlled trials.

Interest & Impact

Downloads

2 since deposited on 23 Apr 2014
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item